The Valley Desk

NCT06833073 · Interventional trial

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Overall registry status Recruiting

Phase 2

Conditions Carcinoma in Situ, Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov